August 2025
Monthly Archives
More stories
-
Trending
Studies on Briumvi in MS Patients During Pregnancy and Breastfeeding
TG Therapeutics Conducting Two Post-Marketing Studies on Briumvi During Pregnancy and Breastfeeding Introduction TG Therapeutics is conducting two post-marketing studies to evaluate the safety of Briumvi among people with relapsing forms of multiple sclerosis (MS) who are pregnant or breastfeeding, as well as their babies. The company aims to generate data on the use of […] More
-
FDA May 2024 Roundup A Month of Progress in Cancer Treatment and Detection
Advancements in Cancer Treatment and Detection Approvals by the FDA in May 2024 Introduction May 2024 saw noteworthy advancements in several areas, including a significant number of FDA approvals, designations, and clearances related to cancer treatment and detection. The following is a detailed overview of the significant approvals and designations from the FDA. FDA Approvals […] More
-
FDA Chooses Moderna’s Rare Disease Candidate for Accelerated Development Program
Moderna’s mRNA-3705: Investigational Therapeutic for Methylmalonic Acidemia (MMA) Moderna Therapeutics, a biotechnology company pioneering the development of mRNA-based medicines, is advancing a novel therapeutic targeting methylmalonic acidemia (MMA) due to methylmalonic-CoA mutase (MUT) deficiency. The investigational therapeutic is known as mRNA-3705, which is designed to instruct the body to restore the missing or dysfunctional proteins […] More
-
Linking Malignant Lymphoma to Tattoos: A New Study Reveals the Connection
Tattoos and Lymphoma: What the Latest Research Reveals The Study’s Findings and Implications A recent study conducted by Lund University’s research team in Sweden reveals that individuals with tattoos may have a greater risk of developing malignant lymphoma, which affects the lymphatic system. However, experts caution that further investigation is needed to establish a definitive […] More
-
Dana-Farber Cancer Institute Teams up with Massachusetts Firefighters to Take on Cancer Risks
Dana-Farber Cancer Institute Partners with Massachusetts Firefighters to Tackle Cancer Risk Dana-Farber Cancer Institute has launched the Direct Connect Partnership with Massachusetts Firefighters to provide support to firefighters who are at a higher risk of developing cancer due to their occupation. The program offers streamlined access to world-class cancer care for firefighters and their families, […] More
-
Tucidinostat + R-CHOP showcases safety & efficacy for DLBCL subtype
Adding Atezolizumab to Chemo/Bevacizumab May Not Be Beneficial in Ovarian Cancer The addition of atezolizumab to chemotherapy and bevacizumab did not lead to improved overall survival (OS) or progression-free survival (PFS) in patients with recurrent ovarian cancer, according to results from the phase 3 IMagyn050 trial. Background Ovarian cancer is a leading cause of cancer […] More
-
EnGeneIC and Singapore Institute of Advanced Medicine Holdings Forge Strategic BioSpace
EnGeneIC Announces Strategic Partnerships with Singaporean Medical Institutions EnGeneIC, a clinical-stage biopharmaceutical company focused on advancing its proprietary targeted nanocell technology for cancer therapy, has announced strategic partnerships with Singapore Institute of Advanced Medicine Holdings (SAM) and Singapore Medical Incorporation (SMI). These partnerships will provide significant funding for EnGeneIC to progress its clinical trials in […] More
-
Brockton Hospital Closed Since Fire Won’t Reopen in June After All
Brockton Hospital Delayed in Reopening with Building Infrastructure Improvements Brockton Hospital, a key healthcare facility that serves patients across the region, will not reopen by June due to issues with heating and air conditioning units. The announcement came after the hospital discovered critical areas for improvement in its building infrastructure during the final phases of […] More
-
EMA Approves Variation for Kite's CAR-T Cell Therapies in Major Breakthrough
The Power of Alternative Medicines in Healthcare The field of medicine has seen tremendous growth since its inception. Over the years, researchers and scientists have dedicated their time to developing new treatments and drugs that have helped improve the quality of healthcare across the globe. While conventional medicine continues to be a crucial aspect of […] More
-
Dana-Farber Teams Up with Firefighters to Tackle Cancer Dangers in Dynamic Partnership WCVB Reveals
Dana-Farber Cancer Institute Partners with Massachusetts Firefighters to Address Occupational Cancer Risks Dana-Farber Cancer Institute, a renowned Boston-based cancer research organization and treatment center, announced its partnership with Massachusetts firefighters to streamline access to specialized cancer care for firefighters and their families. The Direct Connect Program is a new partnership between Dana-Farber Cancer Institute and […] More
-
Engineering Cancer’s End Moffitt Cancer Center
Cancer Engineering: Revolutionizing Cancer Research at Moffitt Cancer Center Cancer touches all of us. Moffitt Cancer Center is a National Cancer Institute-designated comprehensive cancer center, and is at the forefront of bioengineering research with its dedicated department. In a new commentary published in Cancer Cell, W. Gregory Sawyer, Ph. D., and Elsa R. Flores, Ph. […] More
-
Trending
“New Drug in Duke-Led Clinical Trial Shows Improvement in People with Common Autoimmune Disease”
New Drug Shows Promise in Clinical Trials for Sjögren’s Disease Treatment A new drug called dazodalibep, or DAZ, has shown significant benefits in clinical trials for the treatment of Sjögren’s disease, one of the most common autoimmune diseases affecting an estimated 1 to 4 million people in the United States. What is Sjögren’s Disease? Sjögren’s […] More
Load More
Congratulations. You've reached the end of the internet.